AFDIL president Nirbhay Kanoria told ET in an interview that the 100-year-old pharma company is focusing on specialty therapeutic segments such as orthopaedics, women’s health, respiratory and insomnia, along with non-branded generics, with a focus on rural and semi-urban areas. He said the company has launched four divisions and is busy launching new products after the sale of brands to Lupin. “We are reorienting our sales approach from targeting general practitioners to more specialists-driven, in line with our new businesses,” said Kanoria.
